Differentially Expressed MicroRNAs in Osteosarcoma
Author Information
Author(s): Rishi R. Lulla, Fabricio F. Costa, Jared M. Bischof, Pauline M. Chou, Maria de F. Bonaldo, Elio F. Vanin, Marcelo B. Soares
Primary Institution: Children's Memorial Hospital
Hypothesis
Dysregulation of differentially expressed microRNAs may contribute to tumorigenesis.
Conclusion
The study identified 22 differentially expressed microRNAs in osteosarcoma, with 4 confirmed as overexpressed in tumor samples.
Supporting Evidence
- 22 differentially expressed microRNAs were identified.
- 4 miRNAs were confirmed and validated in additional tumor samples.
- miR-135b and miR-150 have been shown to be important in cancer.
Takeaway
Researchers looked at tiny molecules called microRNAs in bone tumors to see how they might help cause cancer. They found some that are more active in tumors than in normal cells.
Methodology
The study used miRNA expression profiling with real-time PCR on osteosarcoma cell lines and tumor samples.
Potential Biases
Potential bias due to using cell lines instead of primary pediatric osteoblasts for comparison.
Limitations
The study had a small sample size and used a normal adult human osteoblast cell line as a control, which may not fully represent pediatric osteoblasts.
Participant Demographics
Pediatric patients with osteosarcoma treated at Children's Memorial Hospital.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website